The first scheduled trial over claims that GSK’s heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed, likely by several months.
Reuters Health Information
The first scheduled trial over claims that GSK’s heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed, likely by several months.
Reuters Health Information
